Clinical Center Logo Home  |  Contact Us  |  Site Map  |  Staff Only  
Patient Recruitment
 
 
More Information
Overweight Individuals with Metabolic Syndrome
Woman smiling.

Doctors at the National Institutes of Health (NIH) invite you to participate in a study looking at the effect of a cortisol blocking medication on glucose and cholesterol abnormalities.

You may qualify if you:

  • Are 35-70 years old
  • Are overweight
  • Have abnormal glucose and triglyceride (a form of ‘bad’ cholesterol) levels but are not on any medications for it

The study involves:

  • Initial screening visit with general health assessment
  • Treatment with a cortisol blocking medication (mifepristone) or non-active pill (placebo) for   seven days. Each individual will take both study agents separated by six to eight weeks
  • Testing before and after study agents will include blood drawing over 24 hours, urine collection, an intravenous glucose tolerance test, and 1-2 day overnight inpatient stay


For more information, please call toll free:
1-800-411-1222
TTY: 1-866-411-1010
Se habla español

Or go online:
clinicaltrials.gov
Refer to study 11-CH-0208

 

Department of Health and Human Services
National Institutes of Health

Eunice Kennedy Shriver
National Institute of Child Health & Human Development

 

NOTE: PDF documents require the free Adobe Reader.

Page last updated: January 12, 2012